CELL AND GENE THERAPY INSIGHTS

February 2018 Issue

Volume 4 Issue 2

Cell and Gene Therapy Insights Volume 4 Issue 2
Download PDF

Featuring

Issue Spotlight: Latest Developments in Viral and Non-Viral Vector Manufacturing
Other articles
Webinar

SPOTLIGHT

Latest Developments in Viral and Non-Viral Vector Manufacturing
Nathalie Clement
Guest Editor:
Nathalie Clement, Associate Professor, Courtesy Faculty at University of Florida

Expert Insight

Downstream bioprocessing of AAV vectors: industrial challenges & regulatory requirements

Downstream bioprocessing of AAV vectors: industrial challenges & regulatory requirements

Matthias Hebben
15 March 2018
Read
Regulatory pathway on the manufacture & quality control of recombinant adeno-associated virus vectors

Regulatory pathway on the manufacture & quality control of recombinant adeno-associated virus vectors

Terence Flotte, Allison Keeler
15 March 2018
Read
Analytical approaches to characterize AAV vector production & purification: Advances and challenges

Analytical approaches to characterize AAV vector production & purification: Advances and challenges

Fabien Dorange, Christine Le Bec
15 March 2018
Read

Innovator Insight

Addressing scaling-up limitations: optimized PEI-mediated production of clinical grade viral vectors

Addressing scaling-up limitations: optimized PEI-mediated production of clinical grade viral vectors

Alengo Nyamay’Antu, Valérie Kedinger, Patrick Erbacher
26 March 2018
Read
Overcoming Downstream Purification Challenges for Viral Vector Manufacturing: Enabling Advancement of Gene Therapies in the Clinic

Overcoming Downstream Purification Challenges for Viral Vector Manufacturing: Enabling Advancement of Gene Therapies in the Clinic

O Terova, P Hermans, J Rooij et al.
25 March 2018
Read

Interview

Addressing the Challenges of Commercial-Scale Viral Vector Production

Addressing the Challenges of Commercial-Scale Viral Vector Production

Nicole Faust
3 April 2018
Read
Merits of non-viral cellular engineering versus viral cellular engineering

Merits of non-viral cellular engineering versus viral cellular engineering

Jessica Carmen
3 April 2018
Read

articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – February 2018

Cell & Gene Therapy Commercial Insight – February 2018

Mark Curtis, Richard Philipson
15 March 2018
Read

Webinars